Objective: To evaluate the feasibility of testing and treating people who inject drugs at a supervised injecting facility for hepatitis C virus (HCV) infection.
Design: Retrospective cohort study.
Setting, Participants: People who inject drugs who attended the Melbourne supervised injecting facility, 30 June 2018 - 30 June 2020.